Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

Upbeat earnings results lift stocks

Video Credit: Reuters Studio - Duration: 01:13s - Published < > Embed
Upbeat earnings results lift stocks

Upbeat earnings results lift stocks

Wall Street advanced Tuesday as the third-quarter earnings season hit the ground running with a spate of upbeat reports that brought buyers back to the equities market.

Fred Katayama reports.


Upbeat earnings results lift stocks

Upbeat reports from several Dow blue chips fueled buying on Wall Street Tuesday as earnings season kicked off.

That allayed investor concerns about fallout from a prolonged U.S.-China trade war.

The three indexes gained more than 9-tenth percent.

Vespula Capital CEO Jeff Tomasulo: SOUNDBITE: VESPULA CAPITAL CEO JEFF TOMASULO (ENGLISH) SAYING: "Now we're in the midst of earnings season.

If we start to see good earnings come in, there's a lot of people so negative I think we're going to get a squeeze - we could, not that I think it's going to happen, we have to see how earnings season progresses - but we could see the market continue to go higher." Healthcare stocks led the rally.

Shares of UnitedHealth Group and Johnson & Johnson MOVED higher.

Both companies raised their profit forecasts.

Financial stocks were also among the top gainers.

Quarterly profit from JPMorgan Chase and Citigroup rose and blasted past analysts' estimates.

Their results showed American consumers are helping to prop up the economy.

But Goldman Sachs shares fell after the investment bank posted declining profit that missed Wall Street's targets.

Tuesday's earnings came as a surprise because Wall Street had forecast the worst quarterly profit performance in about three years for S&P 500 companies.

Reporting later this week: Bank of America, Morgan Stanley and Netflix.

You Might Like

Tweets about this

Recent related videos from verified sources

Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says [Video]Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says

Novartis and its CEO may have gotten a black eye amid a dust-up over tainted research, but the pharma giant is still a buy, according to Jim Cramer during his exclusive video-conference call on..

Credit: The Street     Duration: 02:30Published

Aurora Cannabis Joins The Pot Stock Earnings Miss Club [Video]Aurora Cannabis Joins The Pot Stock Earnings Miss Club

Aurora Cannabis is the newest member of the pot-stocks earnings-miss club. The Canadian recreational cannabis company late on Thursday reported quarterly earnings and sales that missed analysts'..

Credit: The Street     Duration: 01:53Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.